medRxiv preprint doi: https://doi.org/10.1101/2020.07.24.20159368; this version posted July 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Thalamohippocampal atrophy in focal epilepsy of unknown cause at the time of diagnosis Nicola J. Leek1, Barbara A. K. Kreilkamp1,2, Mollie Neason1, Christophe de Bezenac1, Besa Ziso2, Samia Elkommos3, Kumar Das2, Anthony G. Marson1,2, Simon S. Keller1,2* 1Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, UK 2The Walton Centre NHS Foundation Trust, Liverpool, UK 3St George’s University Hospitals NHS Foundation Trust, London, UK *Corresponding author Dr Simon Keller Clinical Sciences Centre Aintree University Hospital Lower Lane Liverpool L9 7LJ
[email protected] Keywords: Newly diagnosed epilepsy, focal epilepsy, thalamus, hippocampus, treatment outcome NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. 1 medRxiv preprint doi: https://doi.org/10.1101/2020.07.24.20159368; this version posted July 25, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license . Abstract Background: Patients with chronic focal epilepsy may have atrophy of brain structures important for the generation and maintenance of seizures.